Patent ID: 9150539
Filing Date: 2015-10-06
Classification: A61K,A61P,C07D

Abstract:
1. Crystalline anhydrous Form II of 3-chloro-5-({1-[(4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl}oxy)benzonitrile: (a) characterized by carbon-13 CPMAS solid state NMR peaks of about: 29.1, 40.8, 101.1, 102.6, 113.0, 117.5, 121.0, 125.1, 128.4, 132.0, 137.9, 143.5, 145.0 and 158.6 ppm; or (b) characterized by x-ray powder diffraction, Cu K alpha, peaks corresponding to d-spacings of about: 9.8, 4.9 and 4.1 angstroms; or (c) having the following endotherms as determined by DSC: